BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17979658)

  • 1. Small interfering RNA in drug metabolism and transport.
    Yu AM
    Curr Drug Metab; 2007 Oct; 8(7):700-8. PubMed ID: 17979658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.
    Shi S; Li Y
    Curr Drug Metab; 2014; 15(10):915-41. PubMed ID: 25828591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microRNAs in the regulation of drug metabolism and disposition.
    Yu AM
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1513-28. PubMed ID: 19785514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species.
    van Groen BD; Nicolaï J; Kuik AC; Van Cruchten S; van Peer E; Smits A; Schmidt S; de Wildt SN; Allegaert K; De Schaepdrijver L; Annaert P; Badée J
    Pharmacol Rev; 2021 Apr; 73(2):597-678. PubMed ID: 33608409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
    Rushmore TH; Kong AN
    Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noise amidst the silence: off-target effects of siRNAs?
    Jackson AL; Linsley PS
    Trends Genet; 2004 Nov; 20(11):521-4. PubMed ID: 15475108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs.
    Yang M; Mattes J
    Pharmacol Ther; 2008 Jan; 117(1):94-104. PubMed ID: 17928059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress on the development of the strategies for siRNAs delivery in vivo].
    Tang D; Mao A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of drug-metabolizing enzymes by local and systemic liver injuries.
    Guo Y; Hu B; Xie Y; Billiar TR; Sperry JL; Huang M; Xie W
    Expert Opin Drug Metab Toxicol; 2016; 12(3):245-51. PubMed ID: 26751558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying siRNA-induced off-targets by microarray analysis.
    Anderson E; Boese Q; Khvorova A; Karpilow J
    Methods Mol Biol; 2008; 442():45-63. PubMed ID: 18369777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing Transcriptional Signatures to Differentiate PXR-, CAR-, and AhR-Mediated Regulation of Drug Metabolism and Transport Genes in Cryopreserved Human Hepatocytes.
    Moscovitz JE; Kalgutkar AS; Nulick K; Johnson N; Lin Z; Goosen TC; Weng Y
    J Pharmacol Exp Ther; 2018 May; 365(2):262-271. PubMed ID: 29440451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference as a gene-specific approach for molecular medicine.
    Grünweller A; Hartmann RK
    Curr Med Chem; 2005; 12(26):3143-61. PubMed ID: 16375707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNA--getting the message out.
    Lee SH; Sinko PJ
    Eur J Pharm Sci; 2006 Apr; 27(5):401-10. PubMed ID: 16442784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin‑3‑O‑β‑D‑glucoside decreases the bioavailability of cyclosporin A through regulation of drug metabolizing enzymes, transporters and nuclear receptors in rats.
    Yang T; Liu Y; Huang X; Zhang R; Yang C; Zhou J; Zhang Y; Wan J; Shi S
    Mol Med Rep; 2018 Sep; 18(3):2599-2612. PubMed ID: 30015887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference: the molecular immune system.
    Bagasra O; Prilliman KR
    J Mol Histol; 2004 Aug; 35(6):545-53. PubMed ID: 15614608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modulation of nuclear receptors on drug-metabolizing enzymes and transporters].
    Liu ZH; Li Y
    Yao Xue Xue Bao; 2012 Dec; 47(12):1575-81. PubMed ID: 23460960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High doses of siRNAs induce eri-1 and adar-1 gene expression and reduce the efficiency of RNA interference in the mouse.
    Hong J; Qian Z; Shen S; Min T; Tan C; Xu J; Zhao Y; Huang W
    Biochem J; 2005 Sep; 390(Pt 3):675-9. PubMed ID: 16004606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.
    Nigam SK; Bush KT; Bhatnagar V; Poloyac SM; Momper JD
    Clin Pharmacol Ther; 2020 Jul; 108(1):40-53. PubMed ID: 32119114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gene silencing by small interfering RNA-based knock-down technology.
    Zhang J; Hua ZC
    Curr Pharm Biotechnol; 2004 Feb; 5(1):1-7. PubMed ID: 14965205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference silencing the transcriptional message: aspects and applications.
    Karkare S; Daniel S; Bhatnagar D
    Appl Biochem Biotechnol; 2004 Oct; 119(1):1-12. PubMed ID: 15496724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.